The state of Tennessee currently has 2 active clinical trials seeking participants for Skin Cancer research studies. These trials are conducted in various cities, including Nashville, Memphis, Knoxville and Chattanooga.
Tranexamic Acid in Nasal Mohs Reconstruction
NCT06057675
Recruiting
This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/09/2024
Locations: Vanderbilt University Medical Center, Nashville, Tennessee
Conditions: Postoperative Bleeding, Skin Cancer Face
Register for Updates
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
NCT03767348
Recruiting
RPL-001-16 is a Phase 1/2, open label, dose escalation and expansion clinical study of RP1 alone and in combination with nivolumab in adult subjects with advanced and/or refractory solid tumors, to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), as well as to evaluate preliminary efficacy.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/01/2023
Locations: West Cancer Center, Germantown, Tennessee
Conditions: Cancer, Melanoma (Skin), Mismatch Repair Deficiency, Microsatellite Instability, Non-melanoma Skin Cancer, Cutaneous Melanoma, NSCLC
Register for Updates